Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit.

Lukshe Kanagaratnam, Rachid Mahmoudi, Jean-Luc Novella, Damien Jolly, Moustapha Dramé, Thierry Trenque
Author Information
  1. Lukshe Kanagaratnam: Department of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Reims, France.

Abstract

INTRODUCTION: Drug prescriptions represent an actionable item in the prevention of adverse drug reactions (ADRs). The aims of this study were to identify risk factors for the occurrence of ADRs, and to describe symptoms and drug interactions.
METHODS: This was a longitudinal study over a period of 19 months in an acute geriatric ward specializing in the management of dementia. Independent risk factors for ADRs were identified by logistic regression. Drug interactions were also recorded.
RESULTS: In total, 293 patients were included (age 82 ± 8 years). The prevalence of ADRs was 24 %. Patients were taking 8 ± 3 drugs per day; 72 (24.6 %) were taking more than three psychotropics. The main therapeutic classes prescribed were anxiolytics and hypnotics (57.7 %), antidementia drugs (54.6 %), antidepressants (54.3 %), antithrombotics (54.0 %), angiotensin-converting enzyme inhibitors [ACEIs] or angiotensin II receptor blockers [ARBs] (37.5 %). The risk of ADRs was significantly higher in patients taking neuroleptics (odds ratio [OR] 2.04; 95 % confidence interval [CI] 1.06-3.92), ACEIs/ARBs (OR 2.07; 95 % CI 1.13-3.77) and antidementia drugs (OR 1.84; 95 % CI 1.01-3.36). The risk of serious ADRs was significantly higher in patients taking ACEIs/ARBs (OR 2.95; 95 % CI 1.40-6.21), type I, III or IV antiarrhythmics (OR 2.71; 95 % CI 1.07-6.88) or neuroleptics (OR 2.42; 95 % CI 1.09-5.40). Drug interactions were involved in 26.3 % (n = 21) of ADRs; the combination of an ADR plus a drug interaction was associated with increased severity (p = 0.02).
CONCLUSION: Caution is needed when prescribing ACEIs/ARBs, neuroleptics, antidementia drugs, or certain types of antiarrhythmics in patients suffering from dementia. Psychotropics should be avoided because of the associated risk of ADRs and drug interactions.

References

  1. J Psychiatr Res. 1975 Nov;12(3):189-98 [PMID: 1202204]
  2. PLoS Med. 2008 Apr 1;5(4):e76 [PMID: 18384230]
  3. J Clin Psychiatry. 2000;61 Suppl 8:43-9; discussion 50-1 [PMID: 10811243]
  4. Arch Intern Med. 2001 Jul 9;161(13):1629-34 [PMID: 11434795]
  5. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):952-60 [PMID: 23794320]
  6. J Clin Epidemiol. 2012 Sep;65(9):989-95 [PMID: 22742913]
  7. Arch Intern Med. 2010 Jul 12;170(13):1142-8 [PMID: 20625022]
  8. J Am Geriatr Soc. 2002 Dec;50(12):1962-8 [PMID: 12473007]
  9. Drugs Aging. 2008;25(11):933-46 [PMID: 18947261]
  10. J Clin Psychiatry. 2001;62 Suppl 21:11-4 [PMID: 11584981]
  11. Am J Manag Care. 2011 Nov;17 Suppl 13:S346-55 [PMID: 22214392]
  12. Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51 [PMID: 18179993]
  13. J Am Geriatr Soc. 2011 Mar;59(3):473-81 [PMID: 21391937]
  14. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003476 [PMID: 16437455]
  15. Am J Geriatr Pharmacother. 2006 Mar;4(1):36-41 [PMID: 16730619]
  16. S Afr Med J. 2006 Dec;96(12):1255-9 [PMID: 17252155]
  17. Eur J Clin Pharmacol. 2007 Aug;63(8):725-31 [PMID: 17554532]
  18. Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):641-51 [PMID: 17154346]
  19. Dement Geriatr Cogn Disord. 2007;23(6):395-400 [PMID: 17396031]
  20. Br J Clin Pharmacol. 1998 Oct;46(4):307-19 [PMID: 9803978]
  21. JAMA. 2002 Sep 25;288(12):1475-83 [PMID: 12243634]
  22. Alzheimers Dement. 2013 May;9(3):338-45 [PMID: 23102979]
  23. Am J Psychiatry. 2000 May;157(5):708-14 [PMID: 10784462]
  24. Arch Gerontol Geriatr. 2005 Jan-Feb;40(1):45-52 [PMID: 15531022]
  25. JAMA. 2003 Mar 5;289(9):1107-16 [PMID: 12622580]
  26. Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1311-8 [PMID: 21919114]
  27. Nephron. 1976;16(1):31-41 [PMID: 1244564]
  28. Eur J Health Law. 2014 Jun;21(3):317-21 [PMID: 25065041]
  29. Drugs Aging. 2005;22(9):767-77 [PMID: 16156680]
  30. Curr Opin Nephrol Hypertens. 2011 Sep;20(5):449-56 [PMID: 21670671]

MeSH Term

Aged, 80 and over
Aging
Angiotensin-Converting Enzyme Inhibitors
Antidepressive Agents
Dementia
Drug Interactions
Drug-Related Side Effects and Adverse Reactions
Female
France
Health Services for the Aged
Hospitalization
Humans
Hypnotics and Sedatives
Long-Term Care
Longitudinal Studies
Male
Prevalence
Prospective Studies
Risk Factors

Chemicals

Angiotensin-Converting Enzyme Inhibitors
Antidepressive Agents
Hypnotics and Sedatives

Word Cloud

Created with Highcharts 10.0.0%ADRs951drugrisk2ORCIinteractionspatientstakingdrugsDrugdementia3antidementia54neurolepticsACEIs/ARBsreactionsstudyfactorsmanagement±82460significantlyhigher21antiarrhythmics=associatedINTRODUCTION:prescriptionsrepresentactionableitempreventionadverseaimsidentifyoccurrencedescribesymptomsMETHODS:longitudinalperiod19monthsacutegeriatricwardspecializingIndependentidentifiedlogisticregressionalsorecordedRESULTS:total293includedage82yearsprevalencePatientsperday72threepsychotropicsmaintherapeuticclassesprescribedanxiolyticshypnotics577antidepressantsantithromboticsangiotensin-convertingenzymeinhibitors[ACEIs]angiotensinIIreceptorblockers[ARBs]375oddsratio[OR]04confidenceinterval[CI]06-3920713-3778401-336serious40-6typeIIIIV7107-6884209-540involved26ncombinationADRplusinteractionincreasedseverityp02CONCLUSION:CautionneededprescribingcertaintypessufferingPsychotropicsavoidedAdverseelderlysubjectshospitalizedspecializedunit

Similar Articles

Cited By